Dr Reddy’s, Cipla, Biocon, Sun Pharma In Focus After WHO Issues Guideline On Use Of GLP-1 Drugs For Obesity

In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.